REAL-TIME GLOBAL RESEARCH
The proof is in the earnings: Bull case for equities increasingly rests on earnings, yet positive outcomes are already priced in, setting a high hurdle to beat; with earnings set to drive further dispersion and idiosyncratic risk dominating, we screen for the most attractive earnings
Research evidence excerpt
The proof is in the earnings: Bull case for equities increasingly rests on earnings, yet positive outcomes are already priced in, setting a high hurdle to beat; with earnings set to drive further dispersion and idiosyncratic risk dominating, we screen for the most attractive earnings
Equity Research
Equity Derivatives Strategy
14 July 2026
The Global Volatility Pulse
The proof is in the earnings
Bull case for equities increasingly rests on earnings, yet
positive outcomes are already priced in, setting a high hurdle
to beat; with earnings set to drive further dispersion and Global Equity Derivatives Strategy
idiosyncratic risk dominating, we screen for the most Anshul+44 (0) 20Gupta7773 0430
anshul.gupta@barclays.comattractive earnings opportunities on both sides of the
Atlantic. Barclays, UK
Stefano Pascale
+1 212 526 7983
Earnings vol Is rich; now earnings need to do the work: Earnings implied moves remain stefano.pascale@barclays.com
elevated across the Atlantic as earnings increasingly need to carry the equity bull case. In the BCI, US
US, the focus is on whether Tech can continue to deliver upgrades. In Europe, the question is Shobhit Mishra
whether improving fundamentals can validate the recent broadening. Indeed, implied earnings +91 (0)22 6175 3536
moves remain rich relative to both realized moves and prevailing volatility regimes, reflecting an shobhit.mishra@barclays.com
exceptionally high idiosyncratic risk backdrop, as evidenced by near-record high single stock vs Barclays, UK
index vol and correlations at fresh all-time lows. US screen: we highlight the top ten names in Zhiyuan Fan
the Barclays AI Disruptors universe with the cheapest implied earnings moves, including, for +1 212 526 5530
instance, Medtronic, FMC, and Digitalocean.
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer